Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03621982 |
Title | Study of ADCT-301 in Patients With Selected Advanced Solid Tumors |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | ADC Therapeutics S.A. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | GBR | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Stanford Cancer Center | Palo Alto | California | 94304 | United States | Details | |
Smilow Cancer Hospital Phase 1 Unit | New Haven | Connecticut | 06511 | United States | Details | |
Oregon Health and Science University | Portland | Oregon | 97239 | United States | Details | |
The Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
The START Center for Cancer Care | San Antonio | Texas | 78229 | United States | Details | |
Institut Jules Bordet | Anderlecht | B-1070 | Belgium | Details | ||
Universitair Ziekenhuis Gent | Gent | 9000 | Belgium | Details | ||
University College London Hospitals NHS Foundation Trust | London | England | NW1 2PG | United Kingdom | Details | |
The Christie NHS Foundation Trust | Manchester | M20 4BX | United Kingdom | Details |